Search results for "treatment"

Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market

Celltrion Files for EU Approval of Cosentyx Biosimilar CT-P55, Targeting $6.7 Billion Autoimmune Market

Celltrion announced on the 24th that it has submitted a marketing authorization application to the European Medicines Agency for CT-P55, a biosimilar...
Numb Calves Led Her to Seek Treatment—But the Culprit Wasn’t Her Knee; It Was Her Lower Back

Numb Calves Led Her to Seek Treatment—But the Culprit Wasn’t Her Knee; It Was Her Lower Back

[Summary] Lumbar spinal stenosis can cause numbness and pain to show up first in the legs or calves rather than the lower back.
Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics Bets 2.7 Trillion Won on Peptides in South Korea’s Largest Biotech M&A Deal

Samsung Biologics is making a major push into peptide-based medicines—widely used in weight-loss and diabetes...
Don't Just Blame Aging: Why Delaying Knee Care Can Cost You Your Mobility

Don't Just Blame Aging: Why Delaying Knee Care Can Cost You Your Mobility

Many people shrug off knee pain—especially when it flares up while walking down stairs—as a natural consequence of...
Sparing the Scalpel: How PRP Therapy Offers a Non-Surgical Lifeline for Chronic Shoulder Pain

Sparing the Scalpel: How PRP Therapy Offers a Non-Surgical Lifeline for Chronic Shoulder Pain

For individuals suffering from chronic shoulder tendon pain, the prospect of surgery can be daunting.
Samsung Medical Center Launches Specialized Committee to Assess Treatment Fitness in Older Cancer Patients

Samsung Medical Center Launches Specialized Committee to Assess Treatment Fitness in Older Cancer Patients

Even among cancer patients in their 70s, the capacity to tolerate major surgery or aggressive chemotherapy varies...
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients

ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients

South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical Secures 145.2 Billion Won MENA Export Deal for Diabetes Drug Enblo

Daewoong Pharmaceutical’s proprietary type 2 diabetes treatment, Enblo (active ingredient: enavogliflozin), is set to...
Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco

Dongkook Pharmaceutical Secures 39 Billion Won Latin American Export Deal for BPH Treatment Uresco

Waking up frequently at night to urinate or noticing a weaker urine stream is a common health concern for men as they...
Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Target the Core: Why 'Deep Remission' Is the New Gold Standard in Inflammatory Bowel Disease Treatment

Treatment for inflammatory bowel disease is rapidly moving beyond simple symptom management toward the structural...